Thailand Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Thailand Pharmaceuticals and Healthcare Report

Thailand Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Thailand Pharmaceuticals and Healthcare Report
Published Oct 22, 2016
103 pages — Published Oct 22, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

Overprescribing and overuse of medicines likely to be tackled in coming years. Free pricing policy in non-institutional sectors, which has been blamed for profiteering, likely to come under scrutiny. ...Government sector reforms capping patient payments for a wide range of treatments potentially leading to a deceleration in market development. Government reliance on copy drugs manufactured exclusively by state-owned producers to discourage multinational expansion within the HIV/AIDS therapeutic market in particular. Use of health economics requirements to threaten values of patented drugs. ...Use of health economics requirements to threaten values of patented drugs. Political conflicts between the National Health Security Office and the Ministry of Public Health can affect provision of medical services.

...BMI View: Reforms to Thailand s healthcare system will influence the commercial opportunities for multinational drugmakers. While a merger of all three schemes remains difficult, incremental reforms in that direction will be forthcoming and necessary for Thailand to address inequalities in healthcare outcomes. ...BMI View: Reforms to Thailand s healthcare system will influence the commercial opportunities for multinational drugmakers. While a merger of all three schemes remains difficult, incremental reforms in that direction will be forthcoming and necessary for Thailand to address inequalities in healthcare outcomes. Pressures to ensure the sustainability of the country s healthcare programmes have also not abated. ...Pressures to ensure the sustainability of the country s healthcare programmes have also not abated. This accentuates the threat of cost containment for drugmakers, which will be heightened should Thailand pursue the target - set by the Committee on Resource Mobilisation for Sustainable Universal Health Coverage - of keeping total health spending less than - of GDP by ----.

...Domestic patent law notably below international standards. High levels of counterfeit and parallel imported medicines in the country. ...

  
Source:
Document ID
1748-2240
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Part of BMI's Industry Report &Forecasts Series24
Executive Summary62
SWOT Analysis84
Pharmaceutical Risk/Reward Ratings123
  Rewards131
  Risks132
Thailand Market Summary152
Regulatory Regime179
  Recent Regulatory Developments181
  Regional Harmonisation191
  Intellectual Property Regime191
  IP Shortcomings201
  Counterfeit Drugs211
  Compulsory Licensing221
  IP Developments231
  Pricing And Reimbursement242
Industry Trends And Developments2613
  Epidemiology261
  Communicable Diseases271
  Healthcare System272
  Healthcare Insurance291
  Medical Tourism302
  Research And Development (R&D)321
  Biosimilars331
  Clinical Trials342
  Medical Devices361
  Developments In The Medical Devices Sector372
Industry Forecast Scenario3923
  Overall Market Forecast392
  Healthcare Market Forecast413
  Key Growth Factors Macroeconomic444
    Prescription Drug Market Forecast482
    Patented Drug Market Forecast502
    Generic Drug Market Forecast522
    OTC Medicine Market Forecast542
    Pharmaceutical Trade Forecast562
  Medical Device Market Forecast582
    Other Healthcare Data601
    Key Risks To BMI s Forecasts611
Competitive Landscape629
  Pharmaceutical Industry621
  Domestic Pharmaceutical Industry632
  Foreign Pharmaceutical Industry651
  Recent Pharmaceutical Industry Developments661
  Pharmaceutical Wholesale671
  Pharmaceutical Retail683
Company Profiles7122
  Domestic Companies7111
  Multinational Companies8211
Demographic Data934
Glossary972
BMI Methodology991
  How We Generate Our Pharmaceutical Industry Forecasts991
Pharmaceuticals Business Environment Ratings1003
  Risk/Reward Ratings Methodology1001
  Ratings Overview1002
  Weighting1021
  Sources1021

Table Of Contents

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Thailand Pharmaceuticals and Healthcare Report" Oct 22, 2016. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Thailand-Pharmaceuticals-and-Healthcare-Report-2026-123>
  
APA:
Business Monitor International - Industry Reports. (2016). Thailand Pharmaceuticals and Healthcare Report Oct 22, 2016. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Thailand-Pharmaceuticals-and-Healthcare-Report-2026-123>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.